Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04054947 · ClinicalTrials.gov registry record · NA

Suicide Prevention in Rural Veterans During High-risk Care Transition Scenarios

A NA study, sponsored by White River Junction Veterans Affairs Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04054947: Completed NA study, sponsored by White River Junction Veterans Affairs Medical Center.

NCT04054947 is a NA study that has completed, run by White River Junction Veterans Affairs Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04054947, a NA study, has completed, sponsored by White River Junction Veterans Affairs Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

In the United States (U.S.), suicide is a major public health concern. U.S. Veterans who live in rural areas may be at even higher risk for suicide than their urban counterparts. Available evidence indicates that suicide risk in rural U.S. Veterans is most concentrated during high-risk care transition scenarios such as discharge from an emergency room. There is limited knowledge about effective interventions to address suicide risk. There is a critical need to develop targeted interventions that address suicide risk during high-risk care transition periods. To be effective, these interventions should address key contributors to suicide risk such as reduced engagement in treatment. This clinical trial evaluates the effect of a suicide prevention intervention to support treatment engagement during high risk transition periods such as discharge from an emergency room.

Primary Outcome

The BSS ranges from 0-38. While there is no established BSS cutoff score to classify suicide risk, there is evidence that higher scores on the BSS correspond to more severe suicidal ideation and that a change of five points or more on the total BSS scores may be clinically relevant. Mean scores at baseline were calculated.

Interventions

  • BEHAVIORAL Suicide Prevention Program

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-10-01
Est. Completion 2022-07-31
Phase NA

What the finished NCT04054947 record still lists

NCT04054947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Suicide Prevention Program is the first listed.

NCT04054947 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04054947 about?

NCT04054947 is a clinical study titled "Suicide Prevention in Rural Veterans During High-risk Care Transition Scenarios". In the United States (U.S.), suicide is a major public health concern. U.S. Veterans who live in rural areas may be at even higher risk for suicide than their urban counterparts. Available evidence indicates that suicide risk in rural U.S. Veterans is most concentrated during high-risk care transiti...

What is the current status of trial NCT04054947?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-10-01. Estimated completion is 2022-07-31.

What interventions are being tested in trial NCT04054947?

The interventions under investigation include: Suicide Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04054947?

This trial is sponsored by White River Junction Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04054947's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04054947, the US trial registry maintained by the National Library of Medicine. NCT04054947 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.